Growth trajectories in lipid profile and fasting blood sugar in prediabetic people over a 16- year follow-up and future risk of type2 diabetes mellitus: A latent growth modeling approach

References

• https://www.who.int/news-room/fact-sheets/detail/diabetes. Available 2020 Jan 13.
   Google Scholar
• Belete B, Biadgo B, Abebe SM, et al. Correlation between serum lipid profile with anthropometric and clinical variables in patients with type 2 diabetes mellitus. Ethiop J Health Sci. 2017;27(3):215–226.
   Web of Science ®Google Scholar
• Joshi SR, Anjana RM, Deepa M, et al. Prevalence of dyslipidemia in urban and rural India: the ICMR-INDIAB study. PloS One. 2014;9(5):e96808.
   PubMed Web of Science ®Google Scholar
• Tomkin GH, Owens D. Diabetes and dyslipidemia: characterizing lipoprotein metabolism. Diabetes Metab Syndr Obes. 2017;10:333–343.
   PubMed Web of Science ®Google Scholar
• Parhofer KG. Interaction between Glucose and Lipid Metabolism: more than Diabetic Dyslipidemia. Diabetes Metab J. 2015;39(5):353–362.
   PubMed Web of Science ®Google Scholar
• Oh YS, Bae GD, Baek DJ, et al. Fatty acid-induced lipotoxicity in pancreatic beta cells during development of type 2 diabetes. Front Endocrinol. 2018;9:384.
   PubMed Web of Science ®Google Scholar
• Inaishi J, Saisho Y. Beta-cell mass in obesity and type 2 diabetes, and its relation to pancreas fat: a mini-review. Nutrients. 2020;12(12):1–16.
   Web of Science ®Google Scholar
• Haile K, Timerga A. Dyslipidemia and Its Associated Risk Factors Among Adult Type-2 Diabetic Patients at Jimma University Medical Center, Jimma, Southwest Ethiopia. Diabetes Metab Syndr Obes. 2020;13:4589–4597.
   PubMed Web of Science ®Google Scholar
• Amini M, Janghorbani M. Diabetes and impaired glucose regulation in first-degree relatives of patients with type 2 diabetes in Isfahan, Iran: prevalence and risk factors. The Review of Diabetic Studies: RDS. 2007;4(3):169–176.
   PubMedGoogle Scholar
• Safari S, Amini M, Aminorroaya A, et al. Patterns of changes in serum lipid profiles in prediabetic subjects: results from a 16-year prospective cohort study among first-degree relatives of type 2 diabetic patients. Lipids Health Dis. 2020;19(193). DOI:10.1186/s12944-020-01371-y.
   Google Scholar
• Rhee E-J, Han K, S-h K, et al. Increased risk for diabetes development in subjects with large variation in total cholesterol levels in 2,827,950 Koreans: a nationwide population-based study. PLoS ONE. 2017;12(5):e0176615.
   Web of Science ®Google Scholar
• Lee S-H, Kim H-S, Park Y-M, et al. HDL-Cholesterol, Its Variability, and the Risk of Diabetes: a Nationwide Population-Based Study. J Clin Endocrinol Metab. 2019 November;104(11):5633–5641.
   Web of Science ®Google Scholar
• International Diabetes Federation. (2019). IDF Diabetes Atlas. 9th Edition.
   Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection EJJ. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 285(19)2486 2001.
   Google Scholar
• World Health Organization %J Nutrition Unit document EIN. Measuring obesity—classification and description of anthropometric data. Report on a WHO consultation of the epidemiology of obesity. Warsaw 1987 Oct 21-23. Copenhagen: WHO, 1989. 1987;123.
   Google Scholar
• Bartolucci F, Farcomeni A, Pennoni F. Latent Markov models for longitudinal data. New York,USA: CRC Press; 2012.
   Google Scholar
• van de Schoot R, Sijbrandij M, Winter SD, et al. The GRoLTS-checklist: guidelines for reporting on latent trajectory studies. Struct Equ Model Multidiscip J. 2017;24(3):451–467.
   Web of Science ®Google Scholar
• Habiba NM, Fulda KG, Basha R, et al. Correlation of lipid profile and risk of developing type 2 diabetes mellitus in 10–14 year old children. Cell Physiol Biochem. 2016;39(5):1695–1704.
   Google Scholar
• Zheng D, Li H, Ai F, et al. Association between the triglyceride to high-density lipoprotein cholesterol ratio and the risk of type 2 diabetes mellitus among Chinese elderly: the Beijing Longitudinal Study of Aging. BMJ Open Diabetes Res Care. 2020;8(1):e000811.
   Web of Science ®Google Scholar
• Safari S, Amini M, Aminorroaya A, et al. Patterns of changes in fasting plasma glucose, hemoglobin A1c and the area under the curve during oral glucose tolerance tests in prediabetic subjects: results from a 16-year prospective cohort study among first-degree relatives of type 2 diabetic patients. Acta Diabetol. 2021;58(3):371–381.
   Web of Science ®Google Scholar
• Drew BG, Rye K-A, Duffy SJ, et al. The emerging role of HDL in glucose metabolism. Nat Rev Endocrinol. 2012;8(4):237.
   PubMed Web of Science ®Google Scholar
• Barter PJ, Rye K-A, Tardif J-C, et al. Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial. Circulation. 2011;124(5):555–562.
   PubMed Web of Science ®Google Scholar
• Drew BG, Duffy SJ, Formosa MF, et al. High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation. 2009;119(15):2103.
   PubMed Web of Science ®Google Scholar
• Rashid S, Watanabe T, Sakaue T, et al. Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity. Clin Biochem. 2003;36(6):421–429.
   PubMed Web of Science ®Google Scholar
• Lehti M, Donelan E, Abplanalp W, et al. High-density lipoprotein maintains skeletal muscle function by modulating cellular respiration in mice. Circulation. 2013;128(22):2364–2371.
   Web of Science ®Google Scholar
• Mortensen SP, Boushel R. High-density lipoprotein: a new therapeutic target for glucose intolerance? Circulation. 2013;128:2349–2350.
   Google Scholar
• Reaven G. Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation. 2002;106(3):286–288.
   PubMed Web of Science ®Google Scholar